Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). 

CEO
Usman Azam
CEOUsman Azam
Employees
41
Employees41
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
41
Employees41

CUE Key Statistics

Market cap
61.31M
Market cap61.31M
Price-Earnings ratio
-1.48
Price-Earnings ratio-1.48
Dividend yield
Dividend yield
Average volume
380.79K
Average volume380.79K
High today
$0.8197
High today$0.8197
Low today
$0.78
Low today$0.78
Open price
$0.81
Open price$0.81
Volume
133.77K
Volume133.77K
52 Week high
$1.99
52 Week high$1.99
52 Week low
$0.5406
52 Week low$0.5406

CUE News

Simply Wall St 5d
Is Cue Biopharma Using Debt In A Risky Way?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky...

Is Cue Biopharma Using Debt In A Risky Way?

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.